InvestorsHub Logo
Followers 21
Posts 1331
Boards Moderated 1
Alias Born 07/02/2013

Re: None

Friday, 09/06/2013 5:27:31 AM

Friday, September 06, 2013 5:27:31 AM

Post# of 300
CEO states that "MiMedx has many of the concerns about the development of the Amniotic Membrane Allograft products as does the FDA." during conf call





http://www.earningsimpact.com/Transcript/83438/MDXG/MiMedx-Group-Inc---Business-Update-Call

I record my personal, subjective observations about the markets, solely for my entertainment and that of interested readers and to foster research. Nothing should be construed as financial advice or an offer or recommendation to purchase or sell any secur

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MDXG News